COSMOS Pharmaceutical Corporation

$41.65

$1.43(-3.32%)

COSMOS Pharmaceutical Corporation

3349.T

$41.65

$1.43(-3.32%)

COSMOS Pharmaceutical Corporation

3349.T

JPX

$41.65

$1.43(-3.32%)

Chart

Upcoming Earnings

Next report date

Apr 13, 2026

Report period

Q2 2026

EPS Estimate

$0.62

Revenue Estimate

$1.67B

Key stats

52-Week Range$41.65

$39.72

$62.85

Market capitalization

$3.97B

Dividend yield (indicated)

1.12%

Price to earnings Ratio (TTM)

16.99

Basic EPS (TTM)

$2.45

Net income (TTM)

$194.01M

Revenue (TTM)

$6.39B

Avg. volume

485.08K

Beta (1Y)

0.21

Employees

5.51K

Market capitalization

$3.97B

Dividend yield (indicated)

1.12%

Price to earnings Ratio (TTM)

16.99

Basic EPS (TTM)

$2.45

Net income (TTM)

$194.01M

Revenue (TTM)

$6.39B

Avg. volume

485.08K

Beta (1Y)

0.21

Employees

5.51K

Screener Quick Check

About COSMOS Pharmaceutical Corporation

Sector

Healthcare

Industry

Medical - Pharmaceuticals

CEO

Hideaki Yokoyama

Website

www.cosmospc.co.jp

Headquarters

Fukuoka Daiichi Building, Fukuoka City, 812-0013

IPO Date

2004-11-11

Identifiers

ISINJP3298400007

Description

COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. It also operates 1,130 stores...

Related Stocks

Sugi Holdings Co.,Ltd.

7649.T

$3,446.00Mkt Cap: $623.63B

Healthcare

Medical - Pharmaceuticals

ISIN:JP3397060009

Welcia Holdings Co., Ltd.

3141.T

$19.77Mkt Cap: $4.10B

Healthcare

Medical - Pharmaceuticals

ISIN:JP3274280001

Dividend Overview

Dividend yield (indicated)

1.12%

Dividend per share

$0.47annual

Payout ratio (Earnings)

—

Payout ratio (FCF)

—

Dividend growth streak

Dividend CAGR (3Y)

-31.7%

Dividend CAGR (5Y)

-11.1%

Dividend CAGR (10Y)

-6.1%

Dividend yield (indicated)

1.12%

Dividend per share

$0.47annual

Payout ratio (Earnings)

—

Payout ratio (FCF)

—

Dividend growth streak

Dividend CAGR (3Y)

-31.7%

Dividend CAGR (5Y)

-11.1%

Dividend CAGR (10Y)

-6.1%

Financials

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate